BIM
AGN

Bridgecreek Investment Management’s Allergan plc AGN Stock Holding History

Bridgecreek Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,965
Closed -$2.86M – 119
2017
Q3 		$2.86M Buy
13,965
+575
+4% +$134K 0.78% 53
2017
Q2 		$3.25M Buy
13,390
+1,050
+9% +$247K 0.87% 50
2017
Q1 		$2.95M Buy
+12,340
New +$2.87M 0.8% 55

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Bridgecreek Investment Management's AGN Position: Q4 2017 in Review

Bridgecreek Investment Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 13,965 shares — an estimated $2.86M sold.

Bridgecreek Investment Management first reported a position in AGN in Q1 2017 and held it in 3 quarters. The position peaked at $3.25M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Bridgecreek Investment Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Bridgecreek Investment Management sold 13,965 Allergan plc shares in Q4 2017, an estimated $2.86M.
  • Bridgecreek Investment Management first reported a position in Allergan plc in Q1 2017 and held it in 3 quarters.
  • Bridgecreek Investment Management's Allergan plc position peaked at $3.25M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Bridgecreek Investment Management's 13F filing for Q4 2017, filed 6 Feb 2018.